Quarterly report pursuant to Section 13 or 15(d)

LEASES

v3.24.3
LEASES
6 Months Ended
Jun. 30, 2024
Leases [Abstract]  
LEASES

5. LEASES

Under ASC 842, Leases, a contract is a lease, or contains a lease, if the contract conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. To determine whether a contract conveys the right to control the use of an identified asset for a period of time, an entity shall assess whether, throughout the period of use, the entity has both of the following: (a) the right to obtain substantially all of the economic benefits from the use of the identified asset; and (b) the right to direct the use of the identified asset. The Company does not assume renewals in the determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. Lease agreements generally do not contain material residual value guarantees or material restrictive covenants.

Leases with an initial term of 12 months or less are not recorded in the condensed consolidated balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. As a practical expedient, the Company elected not to separate non-lease components for the corporate office facility (e.g., common-area maintenance costs) from lease components (e.g., fixed payments including rent) and instead to account for each separate lease component and its associated non-lease components as a single lease component.    

Operating leases

The Company leases a corporate office facility in Denver, Colorado under an operating lease which expires October 31, 2025. The Company entered a sublease for this space during November 2023 for the remaining lease term. The incremental borrowing rate for this lease was 10%.  

During November 2023, the Company entered into a month-to-month lease for corporate office space in Denver, Colorado which expired on June 30, 2024, and was renewed under a new month-to-month lease expiring on August 31, 2024. The Company does not plan to review this lease.

During April 2023, the Company entered a lease for corporate offices space in Houston, Texas, which expires May 2025.  The Company set a notice of termination in April 2024. The incremental borrowing rate for this lease was 7%.

Finance leases

The Company historically leased medical equipment under various financing leases with stated interest rates ranging from 5.2% — 13.4% per annum which expire at various dates through 2026. Finance lease assets are included in assets held for sale as of December 31, 2023. On March 26, 2024, in relation to the sale of certain clinical assets, the Company paid the remaining principal amount due on its outstanding finance leases.  As a result, there are no assets remaining under finance leases nor outstanding amounts due.

The condensed consolidated balance sheets include the following amounts for right-of-use (“ROU”) assets as of June 30, 2024, and December 31, 2023 (in thousands):

    

June 30, 

December 31, 

2024

    

2023

Operating

 

$

457

 

$

616

The following are the components of lease cost for operating and finance leases (in thousands). Finance lease costs are included as a component of loss from discontinued operations in the condensed consolidated statements of operations for the periods presented.

Six Months Ended June 30, 

2024

    

2023

Operating leases:

Amortization of ROU assets

$

190

$

151

Interest on lease liabilities

17

37

Total operating lease cost, included in general and administrative expenses

207

188

Finance leases:

Amortization of ROU assets

152

Interest on lease liabilities

8

25

Total finance lease cost, included in discontinued operations

8

177

Total lease cost

$

215

$

365

During the six months ended June 30, 2024, the Company incurred operating and finance lease principal payments of $183 thousand and $408 thousand, respectively, and $104 thousand and $358 thousand related to operating and finance lease principal payments, respectively, during the six months ended June 30, 2023.  

The following are the weighted average lease terms and discount rates for operating and finance leases:

As of

As of

    

June 30, 2024

June 30, 2023

Weighted average remaining lease term (years):

Operating leases

 

2.6

2.3

Finance leases

 

NA

2.3

Weighted average discount rate (%):

Operating leases

 

9.9

10.0

Finance leases

 

NA

7.9

Future minimum lease payments and related lease liabilities as of June 30,2024, were as follows (in thousands):

    

    

    

Total

Operating

Finance

Lease

Leases

Leases

Liabilities

Remainder of 2024

$

233

$

$

233

2025

 

352

 

 

352

Total lease payments

 

585

 

 

585

Less: imputed interest

 

52

 

 

52

Present value of lease liabilities

533

533

Less: current portion of lease liabilities

 

398

 

 

398

Noncurrent lease liabilities

$

135

$

$

135

Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes.